Finance

Lists
MKL:NYSE
Markel Group Inc
$1,734.05
-0.25%
(-4.28) 1D
Oct 7, 1:16:28 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MKL...
Open
$1,722.70
High
$1,736.02
Low
$1,720.71
Mkt. cap
21.48B
Avg. vol.
72.94K
Volume
29.56K
P/E ratio
9.53
52-wk high
$2,207.59
52-wk low
$1,704.17
EPS
$181.86
Beta
0.64
Shares outstanding
12.39M
No. of employees
23K
Open
$1,722.70
High
$1,736.02
Low
$1,720.71
Mkt. cap
21.48B
Avg. vol.
72.94K
Volume
29.56K
P/E ratio
9.53
52-wk high
$2,207.59
52-wk low
$1,704.17
EPS
$181.86
Beta
0.64
Shares outstanding
12.39M
No. of employees
23K
News stories
From web sources and news partners
Profile
Markel Group Inc. is a group of companies headquartered in Richmond, Virginia, and originally founded in 1930 as an insurance company. Wikipedia
About Markel Group Inc
CEOThomas S. Gayner
Employees22.9K
Founded1930
HeadquartersGlen Allen, Virginia, United States
SectorInsurance
Websitemklgroup.com
Analyst ratings
Based on 2 analysts giving stock ratings to MKL in the past 3 months
Hold
Buy
0
Hold
2
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MKL in the last 3 months.
Highest
Current $1,734.05
$1,950.00 (+12.45%)
Average
$1,950.00 (+12.45%)
Lowest
$1,950.00 (+12.45%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kevin Heal
Argus Research
Hold
Reiterated
-
-
08/13/2026
Mark Hughes
Truist Financial
Hold
Maintained
$1,950.00
+12.5%
07/31/2026
Unknown Analyst
Brean Capital
Hold
Initiated
$2,100.00
+21.1%
03/24/2026
Andrew Kligerman
TD Cowen
Hold
Maintained
$2,107.00
+21.5%
03/13/2026
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$19.79 / $30.57
-35.26%miss
Revenue / Est. (USD)
5.19B / 4.50B
+15.23%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.37B
4.22B
2.82B
5.19B
Cost of goods sold
2.04B
2.11B
1.91B
1.92B
Cost of revenue
2.04B
2.11B
1.91B
1.92B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
1.32B
1.31B
1.19B
1.70B
Total operating expenses
3.36B
3.42B
3.10B
3.63B
Operating income
1.01B
795.15M
-273.33M
1.56B
Other non operating income
-
-
-
-
EBT including unusual items
978.44M
734.16M
-269.94M
1.52B
EBT excluding unusual items
978.44M
734.16M
-269.94M
1.52B
Income tax expense
214.66M
152.07M
-65.58M
332.87M
Effective tax rate
21.94%
20.71%
24.30%
21.92%
Other operating expenses
1.28B
1.27B
1.15B
1.66B
Net income
751.34M
576.81M
-212.29M
1.17B
Net profit margin
17.20%
13.67%
-7.52%
22.54%
Earnings per share
31.61
37.41
23.55
19.79
Interest and investment income
-
-
-
-
Interest expense
-50.68M
-50.02M
-50.89M
-52.39M
Net interest expenses
-50.68M
-50.02M
-50.89M
-52.39M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.06B
1.00B
-229.82M
1.60B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps